OPRK1 and Respiratory insufficiency due to muscle weakness: For example, KOR agonists such as U50,488h, while showing no sign of respiratory depression on their own, Matthes et al., 1998 have been reported to reduce the respiratory depression mediated by icv administration of DAMGO (Dosaka-Akita et al., 1993; Haji and Takeda, 2001).